Results 111 to 120 of about 92,863 (145)

Effects of niacin and omega-3 fatty acids on HDL-apolipoprotein A-I exchange in subjects with metabolic syndrome. [PDF]

PLoS One
Borja MS, Hammerson B, Tang C, Juarez-Serrano L, Savinova OV, Harris WS, Oda MN, Shearer GC.   +7 more
europepmc   +1 more source

Contribution of Apolipoprotein L1 (APOL1) Risk Alleles to Kidney Disease in West Africa: an opportunity for treatment. [PDF]

Ghana Med J
Adu D.
europepmc   +1 more source

Apolipoprotein A-I inhibited group II innate lymphoid cell response mediated by microRNA-155 in allergic rhinitis. [PDF]

J Allergy Clin Immunol Glob
Zeng Y, Zeng Q, Wen Y, Li J, Xiao H, Yang C, Luo R, Liu W.   +7 more
europepmc   +1 more source

Increased Apolipoprotein B/Apolipoprotein A-I Ratio Is Associated With Decline in Lung Function in Healthy Individuals: The Kangbuk Samsung Health Study. [PDF]

J Korean Med Sci
Lee J, Park HK, Kwon MJ, Ham SY, Gil HI, Lim SY, Song JU.   +6 more
europepmc   +1 more source

Enhancing Wound Healing and Anti-Inflammatory Effects by Combination of CIGB-258 and Apolipoprotein A-I against Carboxymethyllysine Toxicity in Zebrafish: Insights into Structural Stabilization and Antioxidant Properties. [PDF]

Antioxidants (Basel)
Cho KH, Lee Y, Lee SH, Kim JE, Bahuguna A, Dominguez-Horta MDC, Martinez-Donato G.   +6 more
europepmc   +1 more source

Low Levels of IgM Recognizing 4-Hydroxy-2-Nonenal-Modified Apolipoprotein A-I Peptide and Its Association with the Severity of Coronary Artery Disease in Taiwanese Patients. [PDF]

Curr Issues Mol Biol
Lei MH, Hsu PW, Tsai YT, Chang CC, Tsai IJ, Hsu H, Cheng MH, Huang YL, Lin HT, Hsu YC, Lin CY.   +10 more
europepmc   +1 more source

HDL-C and apolipoprotein A-I are independently associated with skeletal muscle mitochondrial function in healthy humans.

Am J Physiol Heart Circ Physiol
Giacona JM, Petric UB, Kositanurit W, Wang J, Saldanha S, Young BE, Khan G, Connelly MA, Smith SA, Rohatgi A, Vongpatanasin W.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Apolipoprotein A-I mimetic peptides

Current Opinion in Lipidology, 2010
To review published data related to the potential applicability of apolipoprotein A-I mimetic peptides.Despite a wealth of information on HDL-C levels and risk for cardiovascular disease (CVD), little evidence is present to suggest that raising HDL-C levels per se will result in CVD risk reduction.
G K, Hovingh, Andrea E, Bochem, John J P, Kastelein   +2 more
  +5 more sources

Apolipoprotein A-I

Journal of Pediatric Gastroenterology and Nutrition, 1990
The apolipoprotein (apo) A‐I:B ratio and the apo B concentration were determined by radial immunodiffusion in dried blood spot samples from 1,767 10‐and 11‐year‐old children. Children with either apo A‐I:B ratios below the first percentile or apo B levels above the 99th were recalled and plasma lipid and apolipoprotein profiles were determined for both
Tomas Sveger, Göran Fex, Carl‐Erik Flodmark, Thomas Kjellström, Nils Borgfors   +4 more
openaire   +1 more source

Apolipoprotein A-I in Liver Disease

Scandinavian Journal of Gastroenterology, 1987
Apolipoprotein A-I and high-density lipoprotein concentrations in the plasma of patients with liver disease have been found to be either normal or lower than normal. In this study the apolipoprotein A-I concentration was measured in the plasma of 19 patients with cholestatic liver disease and 21 patients with noncholestatic liver disease.
C H, Florén, J, Franzén, J J, Albers
openaire   +2 more sources